To investigate whether the positive rates of methane and hydrogen breath test were different between the experimental group and the control group.
Small intestinal bacterial overgrowth (SIBO) refers to a syndrome of gastrointestinal symptoms caused by changes in the number and/or type of bacteria in the small intestine, and is considered to be secondary to changes in intestinal anatomy, slowing of intestinal motility, or abnormalities in gastrointestinal function. Clinical symptoms of SIBO are atypical, and are mainly characterized by bloating, belching, abdominal pain, diarrhea, constipation, and changes in stool shape, color, odor, and other characteristics. Since the clinical symptoms of SIBO are not specific and the clinical diagnosis criteria are not standardized, its treatment has not been given enough attention.
Study Type
OBSERVATIONAL
Enrollment
750
Methane and hydrogen breath test results of experimental and control groups
To investigate whether the positive rates of methane and hydrogen breath test were different between the experimental group and the control group.
Time frame: July 1, 2024 to December 31, 2024
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.